|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4439 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/437 | (2013.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/337 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 31/337 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3984537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21193832.9 |
| Date of filing the European patent application | 2014-12-19 | |
| (97) | Date of publication of the European application | 2022-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361919625 P | 2013-12-20 | US |
| (72) |
SAHA, Saurabh , US
WELSCH, Dean , US
DECRESCENZO, Gary , US
ROIX, Jeffrey James , GB
|
| (73) |
Biomed Valley Discoveries, Inc. ,
4435 Main Street Suite 550, Kansas City, Missouri 64111,
US
|
| (54) | CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORS |
| CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORS |